ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

Abstract Background Neoadjuvant therapy is increasingly the standard of care in the management of locally advanced adenocarcinoma of the oesophagus and junction (AEG). In randomised controlled trials (RCTs), the MAGIC regimen of pre- and postoperative chemotherapy, and the CROSS regimen of preoperat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	JV Reynolds, SR Preston, B O’Neill, L Baeksgaard, SM Griffin, C Mariette, S Cuffe, M Cunningham, T Crosby, I Parker, K Hofland, G Hanna, LB Svendsen, CL Donohoe, C Muldoon, D O’Toole, C Johnson, N Ravi, G Jones, AK Corkhill, M Illsley, J Mellor, K Lee, M Dib, V Marchesin, M Cunnane, K Scott, P Lawner, S Warren, S O’Reilly, G O’Dowd, G Leonard, B Hennessy, R Mc Dermott
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-06-01
Colecção:	BMC Cancer
Assuntos:	Oesophageal Oesophagogastric junction Adenocarcinoma Neoadjuvant chemoradiation therapy Neoadjuvant chemotherapy
Acesso em linha:	http://link.springer.com/article/10.1186/s12885-017-3386-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!